Pre- and post-translational regulation of osteopontin in cancer

被引：0

作者：

Pieter H. Anborgh

Jennifer C. Mutrie

Alan B. Tuck

Ann F. Chambers

机构：

[1] London Regional Cancer Program,Department of Pathology

[2] University of Western Ontario,Department of Oncology

[3] London Health Sciences Centre,undefined

[4] University of Western Ontario,undefined

来源：

Journal of Cell Communication and Signaling | 2011年 / 5卷

关键词：

Osteopontin; Cancer; Metastasis; Matricellular protein; Post-translational modification; Alternative splicing;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Osteopontin (OPN) is a matricellular protein that binds to a number of cell surface receptors including integrins and CD44. It is expressed in many tissues and secreted into body fluids including blood, milk and urine. OPN plays important physiological roles in bone remodeling, immune response and inflammation. It is also a tumour-associated protein, and elevated OPN levels are associated with tumour formation, progression and metastasis. Research has revealed a promising role for OPN as a cancer biomarker. OPN is subject to alternative splicing, as well as post-translational modifications such as phosphorylation, glycosylation and proteolytic cleavage. Functional differences have been revealed for different isoforms and post-translational modifications. The pattern of isoform expression and post-translational modification is cell-type specific and may influence the potential role of OPN in malignancy and as a cancer biomarker.

引用

页码：111 / 122

页数：11

共 737 条

[31]

Al-Shami R(2007)Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice Lung Cancer 57 302-623

[32]

Sorensen ES(2009)A functional motif QLYxxYP is essential for osteopontin induced T lymphocyte activation and migration Biochem Biophys Res Commun 380 715-20053

[33]

Ek-Rylander B(2010)A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo Cancer Immunol Immunother 59 355-451

[34]

Andersson G(2007)Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome Mol Cell Proteomics 6 611-14856

[35]

Carson DD(1989)Bone sialoprotein II synthesized by cultured osteoblasts contains tyrosine sulfate J Biol Chem 264 20049-2261

[36]

Farach-Carson MC(2010)Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase Exp Cell Res 316 443-632

[37]

Anborgh PH(1994)Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. modulation of osteoclast adhesion in vitro J Biol Chem 269 14853-674

[38]

Wilson SM(2006)Prognostic significance of osteopontin expression in human prostate cancer Int J Cancer 118 2255-622

[39]

Tuck AB(2001)The functional and clinical roles of osteopontin in cancer and metastasis Curr Mol Med 1 621-1523

[40]

Winquist E(2001)Osteopontin expression in primary sarcomas of the pulmonary artery Virchows Arch 439 668-59

← 1 2 3 4 5 6 7 8 9 10 →